<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04287504</url>
  </required_header>
  <id_info>
    <org_study_id>2115-2019</org_study_id>
    <nct_id>NCT04287504</nct_id>
  </id_info>
  <brief_title>Point-of-care Tests for Bacterial Vaginosis and Candidosis</brief_title>
  <official_title>Validation of the OSOM BVBLUE Test for Bacterial Vaginosis and the SavvyCheck Vaginal Yeast Test for Vaginal Candidosis: A Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vaginal infection in early pregnancy is associated with an increased risk of spontaneous
      preterm delivery and late miscarriage. Most studies presume that vaginal infections are
      responsible for up to 40% of preterm birth. Although the causative microorganisms of vaginal
      infections are manifold, the three pathogens most commonly associated with vaginal infections
      are Gardnerella vaginalis, Candida albicans and Trichomonas vaginalis. The aim of this
      prospective study is the validation of the point-of-care tests OSOM BVBLUE for bacterial
      vaginosis and SavvyCheck Vaginal Yeast Test for candidosis in comparison to Gram stain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the present study, it should be examined whether the OSOM BVBLUE for bacterial vaginosis
      and the SavvyCheck Vaginal Yeast Test for vaginal candidosis are superior, equal/comparable
      or inferior to diagnosis on Gram stained smears. The point-of-care-tests are potential tools
      for the adequate diagnosis of bacterial vaginosis and vaginal candidosis in early pregnancy,
      since the prevention of these infections, as well as the infection screening per se, have the
      potential to prevent preterm birth and reduce the rate of late abortion. Point-of-care-tests
      are easy to perform, relatively cheap, and widely available. Routine implementation of the
      tests would be an effective contribution to the reduction of preterm labor and late-onset
      mortality.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 14, 2020</start_date>
  <completion_date type="Anticipated">February 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Test result of OSOM BVBLUE Test or SavvyCheck Vaginal Yeast Test</measure>
    <time_frame>10 minutes</time_frame>
    <description>Result of point-of-care test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gestational age of delivery</measure>
    <time_frame>approx. 6 months</time_frame>
    <description>To assess preterm delivery rate</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Infection, Bacterial</condition>
  <condition>Infection, Fungal</condition>
  <condition>Preterm Birth</condition>
  <arm_group>
    <arm_group_label>Yeast, control</arm_group_label>
    <description>Women negative for vulvovaginal candidosis on Gram stain smear.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Yeast, study group</arm_group_label>
    <description>Women positive for vulvovaginal candidosis on Gram stain smear.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bacterial vaginosis, control</arm_group_label>
    <description>Women negative for bacterial vaginosis on Gram stain smear.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bacterial vaginosis, study group</arm_group_label>
    <description>Women positive for bacterial vaginosis on Gram stain smear.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>SavvyCheck Vaginal Yeast Test</intervention_name>
    <description>Point-of-care test for the detection of vaginal candidosis</description>
    <arm_group_label>Yeast, control</arm_group_label>
    <arm_group_label>Yeast, study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>OSOM BVBLUE Test</intervention_name>
    <description>Point-of-care test for the detection of bacterial vaginosis</description>
    <arm_group_label>Bacterial vaginosis, control</arm_group_label>
    <arm_group_label>Bacterial vaginosis, study group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Recruitement will take place during routine birth registration at the obstetric outpatient
        clinic at the Department of Obstetrics and Gynecology at the Medical University of Vienna.
        All data will be collected anonymized and encoded with numbers. Pregnant women will be
        screened for asymptomatic and symptomatic vaginal infection via Gram stain as part of
        routine management. Vaginal smears will be assessed by sterile swabs from the lateral
        vaginal wall and posterior fornix vaginae. Two swabs will be collected. The second swab
        will be taken for study purposes to undergo the OSOM BVBLUE Test for bacterial vaginosis or
        the SavvyCheck Vaginal Yeast Test for vaginal candidosis.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Legal age (Participants must be 18 years or over)

          -  Singleton pregnancy

          -  No recent therapy with antibiotics within the last two weeks

          -  No application of the following in the previous 72 hours before testing: vaginal
             ointments/crèmes, douches, spermicides, vaginal lubricants or feminine sprays

        Exclusion criteria:

          -  Age below 18 years

          -  Multiple pregnancy

          -  Recent treatment with antibiotics

          -  Application of the following in the previous 72 hours: vaginal ointments/crèmes,
             douches, spermicides, vaginal lubricants or feminine sprays
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnancy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Herbert Kiss, MD MBA</last_name>
    <role>Study Director</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philipp Foessleitner, MD BSc</last_name>
    <phone>+43140400</phone>
    <phone_ext>28220</phone_ext>
    <email>philipp.foessleitner@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alex Farr, MD PhD</last_name>
    <phone>+43140400</phone>
    <phone_ext>28220</phone_ext>
    <email>alex.farr@meduniwien.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Vienna, Dept. of Obstetrics and Gynecology</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Foessleitner, MD BSc</last_name>
      <phone>+43140400</phone>
      <phone_ext>28220</phone_ext>
      <email>philipp.foessleitner@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Alex Farr, MD PhD</last_name>
      <phone>+43140400</phone>
      <phone_ext>28220</phone_ext>
      <email>alex.farr@meduniwien.ac.at</email>
    </contact_backup>
    <investigator>
      <last_name>Herbert Kiss, MD MBA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 25, 2020</study_first_submitted>
  <study_first_submitted_qc>February 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2020</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Alex Farr, MD PhD</investigator_full_name>
    <investigator_title>Assistant Professor, Consultant Physician</investigator_title>
  </responsible_party>
  <keyword>point-of-care test</keyword>
  <keyword>validation</keyword>
  <keyword>preterm birth</keyword>
  <keyword>bacterial vaginosis</keyword>
  <keyword>candidosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Vaginosis, Bacterial</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Mycoses</mesh_term>
    <mesh_term>Candidiasis</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Vaginal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>on request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

